Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas

NEXT STORY
Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients
PREV STORY
Everest Medicines Announces Positive Results of In Vitro Study of Xerava™ (eravacycline) Against Human Mycoplasmas
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The Top 10 Motivational Speakers To Watch in 2021

author_avatar
NASDAQ Market News

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran

author_avatar
NASDAQ Market News

TRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq® (Atezolizumab) at the American Society of Clinical Oncology Virtual Annual Meeting

author_avatar
NASDAQ Market News